Exact Mass: 637.1828794

Exact Mass Matches: 637.1828794

Found 21 metabolites which its exact mass value is equals to given mass value 637.1828794, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Pelargonidin 3-(6-acetylglucoside)-5-glucoside

Pelargonidin 3-(6-acetylglucoside)-5-glucoside

C29H33O16 (637.1768518)


   

Pelargonidin 3-glucoside-5-(6-acetylglucoside)

5- [ (6-O-Acetyl-beta-D-glucopyranosyl) oxy ] -3- (beta-D-glucopyranosyloxy) -4,7-dihydroxyflavylium

C29H33O16 (637.1768518)


   

Cyanidin 3-(4-acetylrutinoside)

Cyanidin 3-(4-acetylrutinoside)

C29H33O16 (637.1768518)


   

Luteolinidin 5-(3-glucoside-2-acetylglucoside)

5,7,3,4-Tetrahydroxyflavylium 5- (3-glucoside-2-acetylglucoside)

C29H33O16 (637.1768518)


   

Cyanidin-3-(2-acetylrutinoside)

3,5,7,3,4-Pentahydroxyflavylium 3- (2-acetylrutinoside)

C29H33O16 (637.1768518)


   

Malvidin 3-O-(6-O-(3-hydroxy-3-methylglutaryl)-beta-glucopyranoside

Malvidin 3-O-(6-O-(3-hydroxy-3-methylglutaryl)-beta-glucopyranoside

C29H33O16 (637.1768518)


   

Cyanidin-3-(2-acetylrutinoside)

Cyanidin-3-(2-acetylrutinoside)

C29H33O16+ (637.1768518)


   

Akt1-IN-1

Akt1-IN-1

C31H32FN5O5S2 (637.1828794)


Akt1-IN-1 (compound 5b) is a potent and selective Akt1 inhibitor with an IC50 value of 18.79 nM in MIA Paca-2 cells. Akt1-IN-1 does not exhibit obvious teratogenicity, hepatotoxicity and cardiotoxicity (No Observed Adverse Effect Level > 100 μM). Akt1-IN-1 can be used for researching anticancer[1].

   

Cyanidin-3-(2'-acetylrutinoside)

Cyanidin 3-(2'-acetylrutinoside)

C29H33O16 (637.1768518)


   

Cyanidin 3-(4'-acetylrutinoside)

Cyanidin 3-(4'-acetylrutinoside)

C29H33O16 (637.1768518)


   

Pelargonidin 3-(6'-acetylglucoside)-5-glucoside

Pelargonidin 3-(6'-acetylglucoside)-5-glucoside

C29H33O16 (637.1768518)


   

Pelargonidin 3-glucoside-5-(6'-acetylglucoside)

Pelargonidin 3-glucoside-5-(6'-acetylglucoside)

C29H33O16 (637.1768518)


   

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

C32H31NO13 (637.1795316)


   

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

C32H31NO13 (637.1795316)


   

10-amino-3-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

C32H31NO13 (637.1795316)


   

5-{[(2s,3s,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

5-{[(2s,3s,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C29H33O16]+ (637.1768518)


   

2-(1-carboxy-n-{4-[(2s)-2-(carboxyamino)-2-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}-c-hydroxycarbonimidoyl)ethyl]phenyl}formamido)benzoic acid

2-(1-carboxy-n-{4-[(2s)-2-(carboxyamino)-2-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}-c-hydroxycarbonimidoyl)ethyl]phenyl}formamido)benzoic acid

C31H31N3O12 (637.1907646)


   

5-{[(2s,3r,4s,5r,6r)-3-(acetyloxy)-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-1λ⁴-chromen-1-ylium

5-{[(2s,3r,4s,5r,6r)-3-(acetyloxy)-5-hydroxy-6-(hydroxymethyl)-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-1λ⁴-chromen-1-ylium

[C29H33O16]+ (637.1768518)


   

10-amino-3-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

10-amino-3-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-methyl-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione

C32H31NO13 (637.1795316)


   

3-{[(2s,3r,4s,5s,6r)-6-({[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5h-chromen-5-yl

3-{[(2s,3r,4s,5s,6r)-6-({[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5h-chromen-5-yl

C29H33O16 (637.1768518)